EUCRU

Eucrates Biomedical Acquisition Corp. Unit
EUCRU

Delisted

EUCRU was delisted on the 26th of April, 2023.

Back to rankings

23 hedge funds and large institutions have $50.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 18 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$4.06M
2
+$3.36M
3
+$205K
4
Morgan Stanley
Morgan Stanley
New York
+$39K
5
CCM
Condor Capital Management
New Jersey
+$26K

Top Sellers

1
-$9.86M
2
-$6.4M
3
-$3.78M
4
MIM
Monashee Investment Management
Massachusetts
-$3.2M
5
SSA
Schonfeld Strategic Advisors
New York
-$3.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$10M
2
$7.94M
3
$5.03M
4
$4.54M
5
$4.06M
6
$4M
7
$3.36M
8
$3M
9
$2.06M
10
$2.01M
11
$1.18M
12
$965K
13
$829K
14
$801K
15
$440K
16
$331K
17
$120K
18
$115K
19
$39K
20
$27K
21
$26K
22
$11K
23
$1K
24
–
25
–
1
2